Baccoro W., Dumas I., Levy A., Rivin Del Campo E., Canova Ch., Felfely T., Huertas A., Marsolat F., Haie-Meder C., Chargari C., Mazeron R.,
Published online 2017 January 31,
With the increasing use of simultaneous integrated boost in the treatment of cervical cancer, there is a need to anticipate the brachytherapy (BT) contribution at the level of the pathologic pelvic lymph nodes. This study aimed to report the dose delivered at their level during BT.
Read the full article on PubMed →Leave a reply